Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 166,058 |
|
|||||
| News | - | ||||||
| Day High | 0.82 | Low High |
|||||
| Day Low | 0.78 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0126 | 1.58% | 0.8088 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.81 | 0.78 | 0.82 | 0.80 | 0.7962 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 596 | 166,058 | $ 0.8070451 | $ 134,016 | - | 0.67 - 80.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:36 | 1 | $ 0.7803 | USD |
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 432.11k | 533.46k | - | 0 | -17.41M | -32.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptevo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.94 | 0.9649 | 0.78 | 0.8264314 | 206,666 | -0.1312 | -13.96% |
| 1 Month | 0.72 | 1.38 | 0.67 | 1.06 | 1,971,820 | 0.0888 | 12.33% |
| 3 Months | 6.468 | 10.80 | 0.67 | 2.20 | 1,046,372 | -5.66 | -87.50% |
| 6 Months | 8.008 | 10.80 | 0.67 | 3.68 | 685,629 | -7.20 | -89.90% |
| 1 Year | 69.96 | 80.96 | 0.67 | 10.73 | 530,285 | -69.15 | -98.84% |
| 3 Years | 991.32 | 1,397.44 | 0.67 | 392.38 | 579,897 | -990.51 | -99.92% |
| 5 Years | 35.068 | 2,640.00 | 0.67 | 410.86 | 579,109 | -34.26 | -97.69% |
Aptevo Therapeutics Description
| Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. |
